This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other conditions originating in the perinatal period
P16_OTH_COND_ORIGINA_PERINA_PERIOD
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
31 |
4. Check minimum number of eventsNone |
31 |
5. Include endpointsNone |
31 |
6. Filter based on genotype QC (FinnGen only) |
31 |
Control definitions (FinnGen only)
- Control exclude
- P16_OTH_DISORD_ORIGINA_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P9
- Name in latin
- Aliae condiciones origine perinatales
Similar endpoints
↥List of similar endpoints to
Other conditions originating in the perinatal period
based on the number of shared cases.
Similar with more cases:
- Other disorders originating in the perinatal period
- Certain conditions originating in the perinatal period
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2012 | 927 | 1083 |
| Only index persons | 815 | 376 | 439 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 0.08 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 31 | 16 | 15 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 13.45 | 23.97 | 2.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
22
95
5.50
4.82
9.7
6.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
17
63
4.76
4.39
5.5
6.1
e6/l
1.4
0.4
0.69
12
47
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
17
65
4.58
4.17
5.4
5.2
e6/l
0.6
0.4
0.30
12
49
(36304419) Bacteria [Presence] in Urine
19
86
4.12
3.59
9.6
5.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
12
39
4.39
3.54
8.8
4.5
umol/l
10.2
15.2
2.11
12
39
(3042936) Bacteria identified in Isolate by Culture
11
35
4.32
3.31
2.6
2.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
15
63
3.68
3.05
16.3
17.6
—
—
—
0
0
(3012544) pH of Venous blood
16
71
3.59
2.98
16.1
15.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
13
51
3.67
2.90
5.8
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
8
7.18
2.46
1.4
3.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
30
3.80
2.38
1.8
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
9
31
3.66
2.30
1.8
2.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
9
6.37
2.30
1.4
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
12
51
3.21
2.29
5.2
5.0
—
—
—
0
0
(3015736) pH of Urine
18
99
2.95
2.19
12.0
4.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
10
5.72
2.15
1.4
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
15
4.68
2.15
1.3
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
40
3.21
2.08
1.8
2.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
16
4.38
2.04
1.3
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
15
77
2.84
2.04
2.9
4.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
17
4.11
1.94
1.2
2.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
17
4.11
1.94
2.8
2.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
17
4.11
1.94
2.8
2.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
25
178
3.08
1.91
9.8
4.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
12
4.74
1.90
3.4
2.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
21
133
2.79
1.86
9.9
10.1
—
—
—
0
0
(3002256) Pathology report gross observation
7
24
3.46
1.85
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
13
4.36
1.79
1.4
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
7
27
3.04
1.63
1.6
1.2
nmol/l
20.1
17.5
—
7
21
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
41
2.67
1.53
36.8
25.8
mg/l
2.2
1.2
—
9
41
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
41
2.67
1.53
1.3
2.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
18
117
2.28
1.36
7.3
3.8
ug/l
47.8
74.0
0.58
18
112
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
5
18
3.10
1.34
2.0
1.2
%
2.1
1.4
—
5
18
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
17
109
2.24
1.31
10.0
11.4
umol/l
20.4
27.2
0.28
17
102
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.61
1.25
1.2
2.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
20
2.78
1.20
3.0
2.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
31
2.62
1.20
1.7
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
10
53
2.31
1.17
2.2
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
17
113
2.12
1.16
6.9
9.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
7
35
2.28
1.08
8.3
3.8
mg/mmol
15.8
508.4
—
7
23
(3041096) Erythrocytes [Presence] in Urine by Automated
9
51
2.07
1.06
10.1
2.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
37
2.15
1.01
1.3
2.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
37
2.15
1.01
1.9
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
13
82
2.01
0.98
35.2
13.1
mmol/l
1.3
1.4
0.41
13
75
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
16
109
1.97
0.98
9.4
4.1
nmol/l
87.6
72.5
1.61
16
103
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
24
191
2.13
0.93
4.0
3.6
pmol/l
14.4
14.3
0.13
24
180
(3021589) Normoblasts [#/volume] in Blood
22
172
1.96
0.89
16.2
11.1
e9/l
0.0
0.0
0.48
16
129
(3044640) Blood type and Crossmatch panel - Blood
13
85
1.91
0.87
3.7
3.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6
32
2.08
0.87
1.7
4.6
u/l
302.0
261.3
—
6
32
(40760892) CBC W Ordered Manual Differential panel - Blood
9
54
1.94
0.85
23.9
6.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
6
33
2.01
0.84
1.0
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
20
155
1.82
0.75
11.7
4.3
mmol/mol
39.3
37.3
0.28
20
148
(3044889) 12 lead EKG panel
8
119
0.56
0.75
3.8
2.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
26
2.09
0.74
3.0
2.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
80
1.82
0.74
1.8
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
50
1.80
0.68
2.4
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
10
65
1.79
0.65
1.9
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
59
1.74
0.63
2.4
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
20
160
1.70
0.63
5.2
4.1
mmol/l
2.4
2.6
0.48
20
153
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
20
160
1.70
0.63
5.0
3.8
mmol/l
1.5
1.5
0.22
20
153
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
22
0.00
0.62
0.0
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
15
112
1.66
0.60
5.2
4.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
20
162
1.66
0.58
5.1
4.1
mmol/l
4.4
4.5
0.07
20
155
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
11
78
1.64
0.52
9.5
3.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
11
78
1.64
0.52
16.5
14.0
mmol/l
2.0
1.6
—
6
58
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
70
1.63
0.49
3.3
3.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
8
57
1.54
0.47
5.4
6.7
s
29.5
30.6
—
8
57
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
5
33
1.61
0.44
2.2
9.2
%
89.0
89.7
—
5
33
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
5
34
1.56
0.42
1.4
1.3
—
19.9
—
0
8
(3003327) Ova and parasites identified in Stool by Light microscopy
0
17
0.00
0.42
0.0
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11
82
1.53
0.41
10.0
6.3
u/l
36.5
34.5
0.10
11
82
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
18
0.00
0.41
0.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
74
1.52
0.38
15.5
12.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
19
161
1.47
0.38
18.9
7.1
u/l
160.4
135.0
0.56
19
154
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
86
1.43
0.32
24.5
17.7
mmol/l
23.7
24.8
0.70
11
86
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
24
220
1.40
0.27
4.8
4.2
mu/l
1.9
2.1
0.22
24
208
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
41
1.26
0.23
1.8
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
11
0.00
0.22
0.0
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
10
0.00
0.22
0.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
10
0.00
0.22
0.0
1.9
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
10
0.00
0.22
0.0
1.0
—
173.7
—
0
10
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
10
0.00
0.22
0.0
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
2.1
—
36.3
—
0
10
(3006245) CD3-CD19+ cells/100 cells in Blood
0
12
0.00
0.21
0.0
5.0
—
19.1
—
0
12
(3045414) Leukocytes [Presence] in Urine
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
7
57
1.29
0.20
2.3
2.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
10
82
1.32
0.20
13.5
2.8
mmol/l
2.4
2.4
—
10
73
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
26
244
1.41
0.19
4.2
4.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
114
0.82
0.12
1.2
2.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
26
250
1.25
0.09
41.4
13.5
umol/l
91.8
58.7
0.68
26
250
(3003694) ABO and Rh group [Type] in Blood
10
89
1.18
0.08
2.0
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
6
0.00
0.00
0.0
30.7
—
11.7
—
0
6
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
20.6
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
3.6
—
1.8
—
0
7
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
44.3
—
0
7
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
5
0.00
0.00
0.0
1.4
—
258.8
—
0
5
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
9
0.00
0.00
0.0
5.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
52
0.95
0.00
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
0
9
0.00
0.00
0.0
5.4
—
63.1
—
0
9
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
34.2
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
2.6
—
0
5
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
9
0.00
0.00
0.0
5.4
—
26.9
—
0
9
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
0
9
0.00
0.00
0.0
5.3
—
11.3
—
0
9
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
40.4
—
0
5
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
6
0.00
0.00
0.0
5.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
0
5
0.00
0.00
0.0
1.8
—
46.0
—
0
5
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_OTH_COND_ORIGINA_PERINA_PERIOD and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_OTH_COND_ORIGINA_PERINA_PERIOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_OTH_COND_ORIGINA_PERINA_PERIOD – Other conditions originating in the perinatal period
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data